Eelko Hak, PhD

PharmacoTherapy, -Epidemiology and -Economics, Groningen Research Institute of Pharmacy, University of Groningen, 9713 AV Groningen, The Netherlands, Netherlands

Poster(s):

• (073) Pharmacometaboomics suggest a causal link between an excipient in cyclosporine A capsules and incomplete mycophenolate mofetil prodrug activation in kidney transplant recipients
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (083) A Case-control Study On Polypharmacy And Co-medications in Alzheimer’s Disease
  Tuesday, August 27, 2024

  8:00 AM – 6:00 PM CEST

• (098) Dispensing Patterns of Inhaled Asthma Medication Before and During COVID-19 Among Young Adults: A Retrospective Inception Cohort Study
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (104) Determining the cost-effectiveness of pre-emptive genetic testing: an umbrella review
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST

• (157) Comparative effectiveness of anti-hyperlipidemic drugs monotherapy in primary prevention of cardiovascular disease
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (178) Lasso Logistic Regression and Cluster Analysis in Predicting Adherence and Drug Patterns among New Users of Monotherapy for Antihypertensive Drugs: a long-term inception cohort study
  Monday, August 26, 2024

  8:00 AM – 6:00 PM CEST

• (190) Do efficacy results obtained from randomised controlled trials translate to effectiveness data from observational studies for relapsing-remitting multiple sclerosis?
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST